JERSEY CITY, N.J.--(BUSINESS WIRE)--Lux Biosciences, Inc., a privately held biotechnology company specialized in the field of ophthalmic diseases, announced today that Ulrich Grau, President and CEO, will present a company overview at the BIO CEO & Investor Conference 2008 on Monday, February 11, 2008, at 2:00 p.m. ET at The Waldorf-Astoria Hotel in New York City.
